Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
Protein Kinase Targets
Protein Kinase Targets
/
BTK
BTK
BTK
Products (30)
Zanubrutinib
CAS No.:
1691249-45-2
1-[3-[4-Amino-3-[4-(3-ethynylphenoxy)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
CAS No.:
1621002-24-1
4-(4-((4-((3-acrylamidophenyl)amino)-5-fluoropyrimidin-2-yl)amino)phenoxy)-N-methylpicolinamide
CAS No.:
1202759-32-7
Elsubrutinib
CAS No.:
1643570-24-4
Rocbrutinib
CAS No.:
2485861-07-0
Ibrutinib-biotin
CAS No.:
1599432-18-4
Acalabrutinib
CAS No.:
1420477-60-6
Ibrutinib
CAS No.:
936563-96-1
Orelabrutinib
CAS No.:
1655504-04-3
Nemtabrutinib
CAS No.:
2095393-15-8
Tirabrutinib
CAS No.:
1351636-18-4
Atuzabrutinib
CAS No.:
1581714-49-9
Sofnobrutinib
CAS No.:
1646608-10-7
Bms-986142
CAS No.:
1643368-58-4
((plusmn))-Zanubrutinib
CAS No.:
1633350-06-7
Evobrutinib
CAS No.:
1415823-73-2
Cp-547632
CAS No.:
252003-65-9
Docirbrutinib
CAS No.:
2227211-00-7
Biib-091
CAS No.:
2247614-80-6
Fenebrutinib
CAS No.:
1434048-34-6
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact